UTAH MEDICAL PRODUCTS INC
Company Stats
- Market Cap
- $235.8M
- as of Sep 30, 2026
- Shares Outstanding
- 3.2M
- Free Float
- 92.0%
Income Statement
- Revenue
- $38.5M
- Operating Income
- $11.4M
- Net Income
- $11.3M
- EBITDA
- $12.2M
- Revenue Growth, 3Y
- -9.7%
- FCF Margin, 3Y Avg
- 38.7%
- FCF Margin, Worst Year
- 35.7%
Cash Flow
- Free Cash Flow
- $14.3M
- FCF Yield
- 6.1%
- Owner FCF Yield
- 5.9%
Balance Sheet
- Cash & Equivalents
- $85.8M
Returns & Capital
- Dividends Paid
- $4.0M
- Dividend Yield
- 1.7%
- Dividend Payout, 3Y Avg
- 30.6%
- Share Repurchases
- $8.4M
- Buyback Yield, 3Y Avg
- 4.0%
- SBC, 3Y Avg
- $284,667
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $38.5M | $14.3M | 37.2% |
| FY2024 | $40.9M | $14.6M | 35.7% |
| FY2023 | $50.2M | $21.6M | 43.1% |
| FY2022 | $52.3M | $20.3M | 38.9% |
| FY2021 | $49.1M | $20.7M | 42.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 20, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back
Companies Report Firm Demand, Relentless Cost Pressure